ALUME BIOSCIENCES, INC.

Alume Biosciences – Precision Surgery. Illuminating Nerves, Preserving Function

ALUME BIOSCIENCES, INC. was founded in 2019, is headquartered in San Diego, United States, lists 1–10 employees, and has $8.0M in recorded funding across 4 rounds.

Employees
1–10
Founded
2019
Business Model
B2G
Total Funding
$8.0M
Last Round
$1.8M GrantSep 2023
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds for this company. The full record is or through the API.

About

Alume Biosciences is a clinical-stage biotechnology company based in San Diego, California, developing bevonescein (ALM-488), a first-in-class fluorescent nerve visualization drug designed to illuminate peripheral nerves in real time during surgery. Founded by surgeon-scientist Quyen Nguyen, MD/PhD at UC San Diego, the company's technology aims to reduce iatrogenic nerve damage in procedures such as head-and-neck and thyroid surgeries. Alume's Phase 3 pivotal trials met primary endpoints for nerve conspicuity and safety, positioning the company to pursue NDA submission with the US FDA in the second half of 2026.

Summary

ALUME BIOSCIENCES, INC. is a Biotech company based in San Diego, United States, founded in 2019. It lists 1–10 employees. It has raised $8.0M in total across 4 rounds, most recently a $1.8M Grant round in Sep 2023.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Sep 2023
$1.8M

Sign up to see all 4 events

Funding: Grant. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ALUME BIOSCIENCES, INC. on Indexed.vc
<a href="https://indexed.vc/companies/alume-biosciences-inc"><img src="https://indexed.vc/api/badge/company/alume-biosciences-inc" alt="ALUME BIOSCIENCES, INC. on Indexed.vc" width="260" height="76" /></a>